pubmed-article:15459180 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0023443 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C1176472 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0599851 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0521458 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C1514559 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C1414398 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:15459180 | lifeskim:mentions | umls-concept:C0332453 | lld:lifeskim |
pubmed-article:15459180 | pubmed:issue | 23 | lld:pubmed |
pubmed-article:15459180 | pubmed:dateCreated | 2004-11-11 | lld:pubmed |
pubmed-article:15459180 | pubmed:abstractText | Karyotypical alteration of chromosome 5 and in particular band 5q13 is a frequent finding in hairy cell leukemia (HCL). We have previously identified a number of candidate genes localized in close proximity to a constitutional inv(5)(p13.1q13.3) breakpoint in one HCL patient. These included beta-hexosaminodase HEXB, frequently mutated in the lysosomal storage disorder Sandhoff disease. We now report that the 5q13.3 breakpoint disrupts a novel evolutionary conserved alternative isoform of HEXB. This isoform directly overlaps, in a cis-antisense fashion, exon 1 of the gene for ectodermal neuronal cortex 1 ENC-1, and was thus named ENC-1AS. ENC-1 has previously been shown to be overexpressed in several malignancies, and is believed to play a critical regulatory role in malignant transformation of various tumors. Importantly, subsequent analysis of ENC-1 in purified primary HCL tumor cells revealed a striking upregulation of ENC-1 in all 26 patients examined, compared with normal peripheral blood lymphocytes from healthy donors. Upon further analysis of the ENC-1/ENC-1AS locus, we identified a complex 5' regulatory mechanism involving an inverse expression of the ENC-1 sense and the ENC-1AS transcripts in several tissues supporting the hypothesis that expression of ENC-1AS regulates ENC-1 levels. In addition, we have also found tissue-specific methylation of a 1.2 kb segment encompassing the overlapping ENC-1/ENC-1AS 5' exons, adding to the complexity of the regulation of this locus. Altogether, these results suggest that upregulation of ENC-1 contributes to the development of HCL and provides new information on the possible dysregulation of ENC-1 including expression of a novel antisense gene, ENC-1AS. | lld:pubmed |
pubmed-article:15459180 | pubmed:language | eng | lld:pubmed |
pubmed-article:15459180 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15459180 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15459180 | pubmed:month | Dec | lld:pubmed |
pubmed-article:15459180 | pubmed:issn | 0964-6906 | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:SangfeltOlleO | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:EinhornStefan... | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:GrandérDanD | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:MerupMatsM | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:GahrtonGöstaG | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:CorcoranMarti... | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:HammarsundMar... | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:ZhuChaoyongC | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:LernerMikaelM | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:JanssonMonika... | lld:pubmed |
pubmed-article:15459180 | pubmed:author | pubmed-author:Kluin-Neleman... | lld:pubmed |
pubmed-article:15459180 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15459180 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15459180 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:15459180 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15459180 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15459180 | pubmed:pagination | 2925-36 | lld:pubmed |
pubmed-article:15459180 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:meshHeading | pubmed-meshheading:15459180... | lld:pubmed |
pubmed-article:15459180 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15459180 | pubmed:articleTitle | Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia. | lld:pubmed |
pubmed-article:15459180 | pubmed:affiliation | Department of Oncology/Pathology, CCK, Karolinska Hopsital and Institute, Stockholm, Sweden. | lld:pubmed |
pubmed-article:15459180 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15459180 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3074 | entrezgene:pubmed | pubmed-article:15459180 | lld:entrezgene |
entrez-gene:8507 | entrezgene:pubmed | pubmed-article:15459180 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15459180 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15459180 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15459180 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15459180 | lld:pubmed |